1 active not recruiting, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Unknown 1 |
Follow Anal Basaloid Carcinoma: new trials by email Literature Review of Anal Basaloid Carcinoma trials Research Report on Anal Basaloid Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study Biopsy, Biospecimen Collection, Capecitabine - Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 2 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 252 | 2020-01-02 | 2026-10-19 |
| Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer Capecitabine, Carboplatin, Cisplatin - Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 2 | Unknown | ECOG-ACRIN Cancer Research Group | 91 | 2016-08-23 | 2023-06-22 |
Anal Canal Carcinoma (2) · Anus Neoplasms (2)
Anus Diseases (2) · Colorectal Neoplasms (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Rectal Diseases (2) · Rectal Neoplasms (2)
Capecitabine (2) · Fluorouracil (2) · dehydroftorafur (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Biopsy (1) · Carboplatin (1) · Cisplatin (1) · Fluorodeoxyglucose F18 (1) · Magnetic Resonance Spectroscopy (1) · Mitomycin (1) · Mitozytrex (1) · Paclitaxel (1) · Platinum (1) · Radiotherapy, Intensity-Modulated (1) · Specimen Handling (1)
ECOG-ACRIN Cancer Research Group (2)
United States (2)
Cathy Eng (1) · Jennifer A Dorth (1)
U10CA180820 (2)